Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Decitabine facilitates the generation and immunosuppressive function of regulatory γδT cells derived from human peripheral blood mononuclear cells

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

References

  1. Couzi L, Pitard V, Sicard X, Garrigue I, Hawchar O, Merville P et al. Antibody-dependent anti-cytomegalovirus activity of human γδ T cells expressing CD16 (FcγRIIIa). Blood 2012; 119: 1418–1427.

    Article  CAS  PubMed  Google Scholar 

  2. Mariani S, Muraro M, Pantaleoni F, Fiore F, Nuschak B, Peola S et al. Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma. Leukemia 2005; 19: 664–670.

    Article  CAS  PubMed  Google Scholar 

  3. Edelblum KL, Shen L, Weber CR, Marchiando AM, Clay BS, Wang Y et al. Dynamic migration of γδ intraepithelial lymphocytes requires occludin. Proc Natl Acad Sci USA 2012; 109: 7097–7102.

    Article  CAS  PubMed  Google Scholar 

  4. Peng G, Wang HY, Peng W, Kiniwa Y, Seo KH, Wang RF . Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique Toll-like receptor signaling pathway. Immunity 2007; 27: 334–348.

    Article  CAS  PubMed  Google Scholar 

  5. Bansal RR, Mackay CR, Moser B, Eberl M . L-21 enhances the potential of human γδ T cells to provide B-cell help. Eur J Immunol 2012; 42: 110–119.

    Article  CAS  PubMed  Google Scholar 

  6. Zhou J, Appleton SE, Stadnyk A, Lee TD, Nashan BA . CD8+ gammadelta T regulatory cells mediate kidney allograft prolongation after oral exposure to alloantigen. Transpl Int 2008; 21: 679–687.

    Article  CAS  PubMed  Google Scholar 

  7. Gorczynski RM, Chen Z, Hoang Y, Rossi-Bergman B . A subset of gamma delta T-cell receptor-positive cells produce T-helper type-2 cytokines and regulate mouse skin graft rejection following portal venous pretransplant preimmunization. Immunology 1996; 87: 381–389.

    Article  CAS  PubMed  Google Scholar 

  8. Rita Casetti, Chiara Agrati, Marianne Wallace, Sacchi A, Martini F, Martino A et al. Cutting edge: TGF-β1 and IL-15 induce FOXP3+γδ regulatory T cells in the presence of antigen stimulation. J Immunol 2009; 183: 3574–3577.

    Article  Google Scholar 

  9. Li X, Kang N, Zhang X, Dong X, Wei W, Cui L et al. Generation of human regulatory gammadelta T cells by TCRgammadelta stimulation in the presence of TGF-beta and their involvement in the pathogenesis of systemic lupus erythematosus. J Immunol 2011; 186: 6693–6700.

    Article  CAS  PubMed  Google Scholar 

  10. Lal G, Zhang N, van der Touw W, Ding Y, Ju W, Bottinger EP et al. Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation. J Immunol 2009; 182: 259–273.

    Article  CAS  PubMed  Google Scholar 

  11. Choi J, Ritchey J, Prior JL, Holt M, Shannon WD, Deych E et al. In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia. Blood 2010; 116: 129–139.

    Article  CAS  PubMed  Google Scholar 

  12. Beres A, Komorowski R, Mihara M, Drobyski WR . Instability of Foxp3 expression limits the ability of induced regulatory T cells to mitigate graft versus host disease. Clin Cancer Res 2011; 17: 3969–3983.

    Article  CAS  PubMed  Google Scholar 

  13. Dander E, Lucchini G, Vinci P, Introna M, Masciocchi F, Perseghin P et al. Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring. Leukemia 2012; 26: 1681–1684.

    Article  CAS  Google Scholar 

  14. Plumas J, Manches O, Chaperot L . Mechanisms of action of extracorporeal photochemotherapy in the control of GVHD: involvement of dendritic cells. Leukemia 2003; 17: 2061–2062.

    Article  CAS  PubMed  Google Scholar 

  15. Hippen KL, Riley JL, June CH, Blazar BR . Clinical perspectives for regulatory T cells in transplantation tolerance. Semin Immunol 2011; 23: 462–468.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from the National Natural Science Foundation of China (81170526, 81270640), Zhejiang Provincial Natural Science Foundation of China (Y2110127) and China Postdoctoral Science Foundation (2012M520202). We appreciate Novartis AG for providing ZOL and MGI Pharma for providing decitabine for this research.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H Huang.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on the Leukemia website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hu, Y., Cui, Q., Gu, Y. et al. Decitabine facilitates the generation and immunosuppressive function of regulatory γδT cells derived from human peripheral blood mononuclear cells. Leukemia 27, 1580–1585 (2013). https://doi.org/10.1038/leu.2012.345

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2012.345

This article is cited by

Search

Quick links